Sartorius experiences first quarter growth

Sartorius has expressed satisfaction with its financial performance for the first quarter of 2010 after reporting growth across both of its key business areas.

Across the entire group, Sartorius’ consolidated sales revenues increased by three per cent year-on-year to 150.4 million euros (129.8 million pounds), while order intake increased by 6.5 per cent.

This was driven by strong commercial performance in both its biotechnology and mechatronics divisions, with sales of large bioreactor systems and laboratory instruments highlighted as drivers of growth.

As a result, the company confirmed that it will be maintaining its positive forecast for the year, with sales for the year expected to exceed 2009 levels by five per cent.

Dr Joachim Kreuzburg, chief executive officer of Sartorius, said: “These first quarter business results show that both divisions developed entirely within the range of our expectations.”

This comes after the company revealed last month that it was able to achieve increased earnings in 2009 compared to the previous year, despite the impact of the economic downturn.